Crinetics Pharmaceuticals, Inc. (CRNX)
53.18
-1.77
(-3.22%)
USD |
NASDAQ |
Jan 23, 16:00
53.20
+0.02
(+0.04%)
After-Hours: 20:00
Crinetics Pharmaceuticals Research and Development Expense (TTM): 309.89M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 296.43M |
| GT Biopharma, Inc. | 4.026M |
| Axsome Therapeutics, Inc. | 188.68M |
| Sutro Biopharma, Inc. | 200.81M |
| Gossamer Bio, Inc. | 161.14M |